Curaleaf Holdings (OTC) (TSE:CURA) has released an update.
Curaleaf Holdings reports a robust end to 2023 with fourth-quarter revenue reaching $345 million, a 4% increase from the previous quarter, and a significant adjusted EBITDA margin improvement. The company saw a full-year revenue rise to $1.35 billion, a 6% increase from 2022, alongside a notable enhancement in gross margins and operating cash flow. Poised for growth, Curaleaf anticipates 2024 to be a transformative year with a strong brand portfolio and market share in key regions.
For further insights into TSE:CURA stock, check out TipRanks’ Stock Analysis page.
